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Abstract
Background: Extensive spread of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in the United
States, and the concomitant increase in severe invasive staphylococcal infections, including osteomyelitis, in healthy
children, has led to renewed interest in Panton-Valentine leukocidin (PVL). However, the pathogenetic role of PVL in
staphylococcal infections remains controversial, possibly because it depends on the site of infection.
Methodology/Principal Findings: We compared the course of experimental rabbit osteomyelitis due to the PVL-positive
CA-MRSA strain USA 300 (LAC) and its PVL-negative isogenic derivative (LACDpvl), using a low and a high inoculum (8610
5
and 4610
8 CFU). With the low inoculum, bone infection was less frequent on day 7 (D7) and day 28 (D28) with LACDpvl
than with LAC (respectively 12/19 and 18/19 animals, p=0.042). With the high inoculum of both strains, all the animals were
infected on D7 and the infection persisted on D28 in almost every case. However, tibial bacterial counts and the serum CRP
concentration fell significantly between D7 and D28 with LACDpvl but not with LAC. Respectively 67% and 60% of LAC-
infected rabbits had bone deformation and muscle/joint involvement on D7, compared to 0% and 7% of LACDpvl-infected
rabbits (p=0.001 and p=0.005 respectively). Between D0 and D28, the anti-PVL antibody titer increased significantly only
with the high inoculum of LAC.
Conclusions/Significance: PVL appears to play a role in the persistence and rapid local extension of rabbit osteomyelitis, in
keeping with the greater severity of human bone infections due to PVL-positive S. aureus. The possible therapeutic
implications of these findings are discussed.
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Introduction
Panton-Valentine leukocidin (PVL) is a hetero-oligomeric pore-
forming toxin composed of two components (LukS-PV and LukF-
PV) and produced by Staphylococcus aureus. Its prevalence in clinical
S. aureus isolates used to be low but is currently increasing due to
the worldwide spread of PVL-producing community-associated
methicillin-resistant S. aureus (CA-MRSA) strains [1]. Regardless of
methicillin resistance, PVL is particularly prevalent in staphylo-
coccal strains that cause deep skin and soft-tissue infections, severe
necrotizing pneumonia and severe bone and joint infections, all of
which mainly affect children and young adults [2–5].
Extensive spread of CA-MRSA in the United States, mainly due
to the exceptionally infectious strain USA300 [6], and the
concomitant increase in severe invasive staphylococcal infections,
including osteomyelitis, in healthy children [7–9], has renewed
interest in the pathogenic role of PVL. Studies using various
experimental models [10–13] have given conflicting results,
however, raising the possibility that the role of PVL might depend
on the site of infection, as well as the experimental model [14].
Osteomyelitis has long been recognized as a major clinical
syndrome of invasive S. aureus disease [15], accounting for 7% of
staphylococcal infections among children hospitalized in the
United States [9]. A role of PVL in bone and joint infections
was initially suspected by Panton and Valentine [16] and has
recently been the focus of several studies, mostly in the pediatric
setting. In a retrospective study, Martinez-Aguilar et al. [17] noted
that musculoskeletal infection due to PVL-positive community-
acquired (CA) MRSA seemed to be associated with more fever,
longer hospitalization, and more local complications. In a
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caused by PVL-positive S. aureus and PVL-negative S. aureus,
Bocchini et al. found that patients with PVL-positive strains had
significantly stronger inflammatory responses, more local compli-
cations such as myositis and pyomyositis, and more frequently
positive blood culture [18]. Independently, Dohin et al compared
pediatric cases of bone and joint infection caused by PVL-positive
and PVL-negative S. aureus and confirmed that PVL-positive cases
tended to be more severe and to require longer treatment; in
addition, local complications were more frequent and often
necessitated repeated surgical drainage [5].
Several experimental models, using mainly mice but also
rabbits, have been developed in recent years to investigate the
pathogenetic role of PVL, in necrotizing pneumonia, skin
infections, and sepsis [10–12,19], and also to test a PVL vaccine
[19]. However, there have been no experimental studies of PVL in
bone and joint infections.
The purpose of this study was to compare the virulence of the
PVL-positive strainUSA300 and its isogenicpvl-negative derivative in
a rabbit model of acute osteomyelitis. Rabbits were chosen because
their leukocytes are as susceptible as human polymorphonuclear
neutrophils to PVL [20]. Strain USA300 was chosen because it is the
most prevalent PVL-positive CA-MRSA strain in the United States.
Our results clearly showed that PVL plays a role in the
aggressive course of experimental CA-MRSA osteomyelitis, a
result highly consistent with previous clinical observations.
Methods
Bacterial strains
We used a clinical S. aureus strain belonging to the USA300
lineage, and its isogenic DlukS/F-PV derivative (LAC and
LACDpvl, respectively), both kindly provided by Frank DeLeo.
They are described in detail elsewhere and have been used in
murine models of skin infection and pneumonia [11,13,19] and in
a rabbit model of bacteremia [12]. PVL production by the LAC
strain was checked by using a specific ELISA method [21] in the
supernatants of inoculum samples.
Preparation of bacterial inocula
The organisms were stored at 280uC until use. Prior to
experiments they were cultured in casein hydrolysate and yeast
extract medium (CCY) at 37uC for 18 h with shaking. After
centrifugation the supernatants were passed through 0.22-mm
filters and stored at 220uC until PVL quantification by ELISA.
The pellets were washed and resuspended in phosphate-buffered
saline solution (PBS) to the desired bacterial density immediately
prior to inoculation. All inocula were quantified by plating serial
dilutions on tryptic soy agar (bioMe ´rieux- France).
Experimental model
Norden’s method [22] was used to induce osteomyelitis in female
New Zealand white rabbits weighing between 2 and 3 kg. The rabbits
were housed in individual cages and received food and waterad libitum.
The experimental protocol complied with French legislation on
animal experimentation and was approved by the Animal Use
Committee of Maison Alfort Veterinary School. The animals were
anesthetized by intramuscular injection of 25 mg/kg ketamine
(Vibrac France) and 25 mg/kg Xylazine RompumH 2% (Bayer
Sante ´, Division Sante ´ Animal, Puteaux, France). Before S. aureus
challenge (on day 0), 500 ml of venous blood was drawn and serum
was stored at 220uC. An 18-gauge needle was inserted percutane-
ously through the lateral aspect of the right tibial metaphysis into the
medullary cavity. Infection was induced by direct injection of
sclerosing agent (0.1 ml of 3% sodium tetradecyl sulphate (Trombo-
varH)), followed by 0.2 ml of inoculum and 0.1 ml of saline. Patch
analgesia (DurogesicH) was given for 7 days following surgery.
Animals were assigned to receive a low inoculum (8610
5 CFU) or
ah i g hi n o c u l u m( 4 610
8 C F U )o fL A Co rL A C Dpvl in order to detect
a possible inoculum effect on PVL expression. These inocula were
selected on the basis of pilot experiments designed to determine the
dose necessary to induce persistent infection with each strain in more
than 85% of animals 28 days after inoculation. LAC and LACDpvl
challenge was always performed simultaneously in order to minimize
the influence of experimental conditions. Since a chromosomally-
restored derivative of the LACDpvl was not available, no comple-
mentation group was included in the experiment.
Macroscopic aspect and bacterial density of bone
The animals were monitored daily for general and local signs of
infection (mobility, aspect of the legs) and were weighed weekly.
Moribund animals (immobile, unable to be aroused from a
recumbent position, and unable to access food and water) were
euthanized by rapid intravenous injection of pentobarbital [23].
Animals were killed 7 days (D7) or 28 days (D28) after infection
in order to assess the impact of PVL on the time course of
osteomyelitis. Before sacrifice, venous blood was drawn for blood
culture and serum samples ($500 ml) were stored at 220uC for
later determination of anti-PVL antibody and C-reactive protein
titers. The right leg was visually examined, the tibia and femur
were dissected out from the surrounding soft tissues, and the knee
joint space, soft tissues, compact bone and medulla were grossly
inspected. The following variables were evaluated: the presence
and location of purulent exudates in the joint space; soft tissue and
bone abscesses; the severity of tibial metaphysis deformation; and
spread of the infection to the tibial diaphysis. The macroscopic
aspect was noted and photographed. Several evaluations were
made on photographs, by an investigator who was unaware of the
group attribution. The blinded evaluation was reproducible and
consistent with autopsy findings.
The upper third of the tibia was frozen in liquid nitrogen,
crushed in a pulverizer (Spex 6700; Freezer/Mill Industries
Metechen, NJ), suspended in 10 ml of sterile saline, and
quantitatively cultured on tryptic soy agar. Samples of pulverized
tibia and subcutaneous abscess fluid were also stored at 220uC for
microbiological studies of bone isolates.
Imaging studies and histopathological examination
Serial MRI was performed on 6 rabbits infected with the low
inoculum (3 with LAC and 3 with LACDpvl) at 7, 14 and 21 days
post-infection. These rabbits were killed 28 days post-infection for
macroscopic examination and tibial bacterial counts.
MRI, coupled with plain radiography and histopathological
examination of the infected legs, was also performed on two
animals injected with ThrombovarH alone, 6 animals challenged
with the high inocula and killed 7 days post-infection (3 with LAC
and 3 with LACDpvl) and 8 animals killed 28 days post-infection (4
with LAC and 4 with LACDpvl). In these rabbits, muscle and joint
involvement was recorded on the basis of gross signs and
histological examination.
MR imaging was performed with a 1.5-Tesla device (Intera;
Philips Medical System, Eindhoven 5600 PB, Netherlands)
equipped with a surface coil (Sense-Flex-S). The anaesthetized
animal (Ketamine and Xylazine RompumH 2%) was placed on its
back with the lower limbs extended. The MR imaging protocol
included several classical sequences (T1, T2, PD SPIR, STIR, and
3D WatSF), using a 140-mm field of view. The 3D WatSF
sequence (TR: 20 ms, TE: 7.5 ms, flip angle of 50u, matrix
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acceptable reformatted images in the frontal or sagittal plane of
the tibia. Moreover, this water-selective sequence was most
sensitive for changes due to the infection, the replacement of
yellow (lipid) marrow by water representing the earliest abnor-
mality. Images were acquired and examined by a radiologist who
was unaware of the group attribution.
For histopathological studies, the right leg, including half the
femur, the entire tibia and the foot, was excised. The skin was
removed and the leg was fixed for 48 hours in phosphate-buffered
10% formaldehyde. The tibia and femur were then decalcified in
10% nitric acid for 48–72 hours. A perpendicular section was cut
through the knee and patella and was used to prepare serial
macroscopic slices including the knee, the entire tibia and the
distal femur. These slices were dehydrated in alcohol and
embedded in paraffin. Histological sections 4 mm thick were then
cut and stained with hemalun-eosine-safran (HES). Some samples
were also Gram stained. The slides were examined by a
pathologist who was unaware of the group attribution. The
following parameters were evaluated for each joint, bone and
muscle specimen: 1) inflammation (presence, stage, main inflam-
matory cells), 2) other pathological changes, such as fibrosis,
edema, necrosis, and abscesses; and 3) presence of bacteria.
Serum antibody assay
Antibodies against PVL (before S. aureus challenge and at
sacrifice) were measured with a specific ELISA method. Specific
anti-LukS-PV antibodies were quantified with a protocol adapted
from Croze et al [24], with a peroxidase-conjugated swine anti-
rabbit polyvalent IgG diluted 1:1000 (DAKO). Serial dilutions of
anti-luk-S polyclonal rabbit serum (bioMe ´rieux) were used for
calibration. The results were expressed in arbitrary units per
milliliter (AU/mL), one arbitrary unit corresponding to the
amount of anti-LukS-PV antibodies contained in a 1/107 dilution
of the polyclonal rabbit reference serum.
C-reactive protein (CRP) assay
CRP was assayed in serum by using a specific ELISA method,
as recommended by the provider (ALPCO).
Statistical analysis
Percentages (of infected animals, bone marrow involvement,
bone deformation, and muscle or joint involvement) were
compared with Fisher’s exact test. The non parametric Mann-
Whitney U test was used to compare tibial bacterial counts and
anti-PVL antibody and CRP titers. P values ,0.05 were
considered to denote significant differences.
Results
Selection of inoculum sizes
Preliminary studies were performed with three inocula, of
8610
5 CFU, 4610
6 CFU and 4610
8 CFU. Six animals chal-
lenged with each inoculum were killed on D7 and D28. The low
inoculum of LAC and the high inoculum of LACDpvl induced
persistent infection on D28 in respectively 90% and 86% of
animals, and were therefore used in the rest of the study.
Characteristics of osteomyelitis induced by the low
inocula
All rabbits challenged with the low inoculum of LAC (n=19) or
LACDpvl (n=19), including the animals used in the preliminary
inoculum-ranging experiments, were used for macroscopic and
microbiological evaluation. One animal each in the LAC and
Figure 1. Bacterial counts in rabbit tibia. Box plot representation (10, 25, 50, 75, 90th percentiles and outliers) of bacterial counts in rabbit tibia 7
days (D7) and 28 days (D28) after inoculation with 8610
5 (low) or 4610
8 (high) CFU of LAC and LAC Dpvl CA-MRSA. P values for differences between
D28 and D7 were obtained with the non parametric Mann-Whitney U-test.
doi:10.1371/journal.pone.0007204.g001
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Nine rabbits in each group were sacrificed on D7 and on D28.
Mean body weight changed significantly on D7 in the LACDpvl
group (+7.5%, P=0.025 vs D0) but not in the LAC group (+3.5%,
P=0.31 vs D0). Significant weight gain was observed in the two
groups on D28 (+29% and +34% in the LAC and LACDpvl
groups, respectively; P,0.001 vs D0 in both groups)
Combined analysis of the D7 and D28 results showed that
significantly more rabbits challenged with LAC than with
LACDpvl had infected bone (18/19 vs 12/19, P=0.042),
suggesting that PVL enabled better colonization by and/or
survival of the parental strain LAC. However, bacterial counts
in crushed bone were similar in the two groups (Figure 1).
Bacterial counts tended to be lower on D28 than on D7 (Figure 1).
Macroscopically, the infection mainly involved bone marrow
which was yellow/white in all infected animals and necrotic in two
animals in each group. Bone deformation was observed in only 4/
38 animals overall (3/19 and 1/19 in the LAC and LACDpvl
groups, respectively; P=0.60) and muscle abscesses were present
in only 2/38 animals (2/19 and 0/19 respectively; P=0.49).
Serial MRI studies, performed on 3 animals in each group,
systematically showed signs of infection on all but the T1 sequences,
with a marrow hypersignal initially restricted largely to the
metaphysis; it gradually became more intense in 3 rabbits (2 LAC,
1 LACDpvl) (Figure 2A), remained stable in 2 rabbits (1 LAC, 1
LACDpvl), and was already severe on D7 (extending to the
diaphysis) in 1 rabbit (1 LACDpvl, Figure 2B). Thus, both the
PVL-positive strain and its PVL-negative derivative caused severe
bone marrow involvement.
Characteristics of osteomyelitis induced by the high
inoculum
Respectively 29 and 26 rabbits received the high inocula of
LAC and LACDpvl. Six animals (4 LAC and 2 LACDpvl) died or
were euthanatizied prematurely. Respectively 11 and 12 rabbits
infected with LAC and LACDpvl were killed on D7, and 7 and 5
rabbits were killed on day 28 for microbiological evaluation and
macroscopic inspection.
Macroscopic findings were also recorded in the 14 rabbits (7 in
each group) used for imaging and histopathological studies.
On D7, body weight loss was significant and similar in the two
groups (average 28% with LAC and 210% with LACDpvl;P=0.014
and P,0.0001 vs D0, respectively), reflecting more severe disease
than that observed with the low inocula. Body weight returned to
baseline by D28, with similar weight recovery in the two groups.
All the animals had infected bones on D7, and the infection
persisted on D28 in 90% and 86% of animals challenged with
LAC and LACDpvl, respectively. As with the low inoculum, mean
bacterial counts were lower on D28 than on D7 (Figure 1).
However, the decline was significant in rabbits challenged with
LACDpvl but not in those challenged with LAC, again suggesting
that PVL enhanced bacterial survival.
Osteomyelitis induced by the high inocula was associated with
severe local macroscopic changes at autopsy, with bone marrow
Figure 2. Serial MRI of a rabbit challenged with a low inoculum of LAC (PVL+) or LACDpvl (PVL2). 2A - Serial magnetic resonance imaging
(MRI) of a rabbit infected with a low inoculum of LAC (PVL+); the mean tibial bacterial count was 4.64 Log10 CFU/g of bone on D28. The infection
appears as a marrow hypersignal on D7, that becomes more intense and extends to the entire diaphysis on days 14 and 21. A medullary abscess was
found at autopsy on D28. 2B - Serial MRI of a rabbit challenged with a low inoculum of LACDpvl (PVL2). An intramedullary abscess was visible in the
metaphysis and proximal diaphysis on D7, appearing as an intense marrow hypersignal. Central necrosis was noted on images obtained on D14 and
D21. Bone marrow necrosis was observed macroscopically on D28. The mean tibial bacterial count on D28 was 6.08 Log10 CFU/g of bone.
doi:10.1371/journal.pone.0007204.g002
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(localized abscesses, myositis, sinus tract) and joint (purulent
arthritis) in some rabbits (Figure 3, Table 1). Bone deformation
and muscle/joint involvement were seen in respectively 67% and
60% of LAC-infected rabbits on D7, compared to respectively 0%
and 7% of LACDpvl-infected rabbits (P=0.001 and P=0.005
respectively) (Figure 3). On D28 the frequency of bone
deformation was similar in the two groups (,60%), while
muscle/joint involvement was still significantly more frequent
with LAC than with LACDpvl (57% versus 9%, P=0.033). Thus,
PVL+ osteomyelitis was an acute infection with rapid local
extension, contrary to PVL2 osteomyelitis.
MRI and plain radiography, performed on 7 LAC-infected and 7
LACDpvl-infected rabbits, showed the same signal modifications as
in the rabbits challenged with the low inocula. However, imaging of
isolated legs, used for the high-inoculum group, was less informative
than imaging of live animals (used for the low-inoculum group), thus
explaining why no modifications were seen on Day 7 in the high-
inoculum group. Radiographic changes were apparent on D28 in
half the rabbits infected with LAC (2/4) and LACDpvl (2/4), with
widening and deformation of the tibial metaphysis and diaphysis,
ostelysis, and subperiosteal osteogenesis. Typical radiological and
histological aspects in infected rabbits, and their correspondence
with macroscopic findings, are shown in Figure 4.
Anti-PVL antibody titers
Anti-PVL antibodies were measured in blood drawn before
infection (D0) and at the time of sacrifice (D28) (Figure 5). The
median anti-PVL titer in rabbits infected with the high inoculum
of the LAC strain increased 31-fold on D28 (range 39 190–613
100 AU/mL, median 121 350 AU/mL) versus D0 (range 1 270–4
220 AU/mL, median 3 129 AU/mL). No significant change in
the anti-PVL titer was detected on D28 after challenge with
LACDpvl, at either the high inoculum (D0 range 1 490–4
330 AU/mL, median 3 620 AU/mL; D28 range 1 490–6
894 AU/mL, median 3 841 AU/mL) or the low inoculum (D0
range 1 215–3 870 AU/mL, median 2 388 AU/mL; D28 range 1
284–16 290 AU/mL, median 2 905 AU/mL), or with the low
inoculum of the LAC parent strain (D0 range 1 233–5 164 AU/
mL, median 2 852 AU/mL; D28 range 1 391–18 650 AU/mL,
median 3 761 AU/mL).
PVL production in vitro and in vivo
PVL production by strains recovered from the inocula and
infected bones was measured in vitro and remained constant,
ranging from 7.5 to 10 mg/ml LukS-PV. The PVL concentration
was also measured in some pus samples. As much as 0.65 mg/ml of
Figure 3. Bone and muscle/joint involvement after challenge with a high inoculum of LAC and LAC Dpvl. Percentages of rabbits with
bone marrow involvement, bone deformation and muscle/joint involvement 7 (D7) and 28 (D28) days after challenge with a high inoculum of LAC
and LAC Dpvl. n is the total number of animals. P values for differences between the c and LAC groups were obtained with the non parametric Mann-
Whitney U-test.
doi:10.1371/journal.pone.0007204.g003
Table 1. Macroscopic findings in rabbits challenged with a
high inoculum: details of soft tissue and joint changes.
Strain Days Purulent arthritis Abscess Myositis
Sinus
tract
LAC D7 1/15 6/15 0/15 2/15
D28 4/14 2/14* 3**/14 2/14
LAC D pvl D7 0/15 1/15 0/15 0/15
D28 1/11 0/11 0/11 0/11
Results are expressed as number of rabbits with muscle/joint involvement on
total number of rabbits challenged with LAC or LAC D pvl.
*including one rabbit with concomitant purulent arthritis.
**including two rabbits with concomitant purulent arthritis.
doi:10.1371/journal.pone.0007204.t001
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strain-infected animal.
CRP
C-reactive protein levels were measured on D7 and D28 after
challenge with the high inocula of LAC and LACDpvl. CRP levels
were high in both groups on D7 (LAC: 100.6–924.0 mg/L,
median 287.0 mg/L; LACDpvl: 91.3–879.9 mg/L, median
306.8 mg/L), and fell on D28, significantly with LACDpvl
(p=0.002) but non significantly with LAC (p=0.085) (figure 6).
Discussion
Hematogeneous osteomyelitis has long been recognized as a
major clinical syndrome of S. aureus disease in children. Since the
antibiotic era, acute osteomyelitis has become a less frequent cause
of hospital admission and death [15]. Concomitantly with the
recent worrying emergence of CA-MRSA strains, the incidence of
S. aureus osteomyelitis, which represents 7% of infections due to
staphylococci in hospitalized children in the United States,
doubled between 2002 and 2007 [9].
Panton and Valentine themselves suspected a role of PVL in
osteomyelitis [25], reporting that the leukocidin was produced in
large amounts by staphylococcal strains causing severe infections
[16]. Yet no experimental studies of the impact of PVL on the
course of osteomyelitis have been conducted to date. Here we
provide evidence that PVL plays a role in rabbit CA-MRSA
osteomyelitis, i) by enhancing the persistence of the infection, even
with a low inoculum, and ii) by facilitating local extension during
the early phase of infection after challenge with a high inoculum.
More rabbits had infected bones on D7 and D28 after challenge
with a low inoculum of LAC than with a low inoculum of the PVL-
negative isogenic derivative, suggesting that PVLenhances bacterial
persistenceatthesite ofinfection.PVLhad asimilarbutlessmarked
influence after challenge with the high inoculum. Our findings are
consistent with the recent report by Diep et al, which suggests that
PVL plays a role in the early stages of rabbit CA-MRSA bacteremia
by enhancing the survival and spread of the strain USA300 [12].
Figure 4. Typical radiological and histological findings after challenge with a high inoculum of LAC (PVL+). A, B, C: Radiological and
histological findings 28 days after challenge with a high inoculum of LAC (PVL+). Note the major deformation and widening of the entire diaphysis,
compared to the control animal injected with sclerosing agent alone. Histological studies showed an intramedullary abscess and signs of chronic
osteomyelitis. B: Bone abscess: the bone marrow space is filled with altered neutrophilic PMN, accompanying bone destruction and necrosis. C:
Sequestrum: area of necrotic bone surrounded by an acute inflammatory exudate (pus). D, E, F: 28 days after challenge with a high inoculum of LAC
(PVL+), note the soft tissue abscess surrounded by a fibrous layer on MRI and histological studies. G, H, I: Histological findings in a rabbit (PVL+) that
died on D8 after challenged with a high inoculum of LAC. Histological sections (H) show muscle involvement with diffuse necrosis and dystrophic
calcification, and (I) a purulent exudate in the joint cavity.
doi:10.1371/journal.pone.0007204.g004
PVL in CA-MRSA Osteomyelitis
PLoS ONE | www.plosone.org 6 September 2009 | Volume 4 | Issue 9 | e7204PVL-positive osteomyelitis induced by the high inoculum
caused bone deformation and muscle/joint involvement in more
than 60% of rabbits, as early as 7 days post-infection. In contrast,
the PVL-negative isogenic derivative failed to cause bone
deformation or muscle involvement on D7, while muscle
involvement was infrequent and less severe 28 days post-infection
than with the parent strain.
A determining role of PVL in muscle extension has been also
observed in a mouse model of skin infection: severe myositis was
observed in mice inoculated subcutaneously with LAC but not in
those inoculated with LACDpvl [19]. These experimental findings are
consistent with the more severe local disease observed in children and
young adults with osteomyelitis due to PVL-producing strains.
Bocchini et al [18] have shown that patients infected with PVL+ S.
aureus isolates are significantly more likely to have concomitant
myositis or pyomyositis than are patients with PVL2S. aureus isolates.
Dohin et al [5] showed that patients with PVL+ infection were more
likely to have abnormalities on initial radiographic examination, a
finding suggesting a more aggressive course.
PVL targets immune cells such as polymorphonuclear neutro-
phils (PMNs), monocytes and macrophages. Depending on the
concentration, PVL-induced pores cause cytokine release and cell
death by apoptosis or necrosis, thus enhancing the inflammatory
response and causing extensive tissue necrosis [26]. The leukotoxic
activity of PVL could thus explain the differences in soft tissue
involvement observed here between the PVL+ and PVL2 strains.
The inflammatory response to S. aureus also seems to be enhanced
by PVL in the clinical setting, with a higher erythrocyte
sedimentation rate (ESR) and a higher C-reactive protein level
[5]. We found no difference in the day-7 CRP level between
animals infected with LAC and LACDpvl. In contrast, the CRP
level fell significantly on D28 in animals infected with LACDpvl
but not in those infected with the PVL-positive parent strain LAC.
This fall in the CRP level in LACDpvl-infected rabbits coincided
with a decline in bacterial counts in bone. Conversely, the
persistently high CRP levels in LAC-infected rabbits were
associated with severe extra-osseous involvement and were
possibly related to the proinflammatory properties of PVL.
Anti-PVL antibody titers rose markedly in rabbits challenged
with the high inoculum of the LAC strain. This in keeping with
reports that, compared to children with soft-tissue infections,
children with invasive S. aureus infections (including pneumonia
and bone and joint infections) develop dominant anti-LukF and -
LukS responses that correlate with markers of inflammation [27].
As virulence gene expression depends on the location and the
stage of infection [14], the use of an appropriate experimental
model is crucial to understand the impact of PVL in human bone
and joint infections. The model used here resembles pediatric
hematogenous osteomyelitis in several respects [28]. First, the
infection begins in the tibial metaphysis and progresses to diffuse
osteomyelitis. As in humans, it becomes chronic if left untreated
[15]. MRI signs can be detected as early as day 5 after inoculation
[29], followed by radiographic changes [22]. In contrast, unlike
acute osteomyelitis in children, this model involves local
inoculation and requires the use of a sclerosing agent to create
small-vessel thrombosis and micronecrosis, thereby enhancing
bacterial proliferation [30]. Attempts to induce experimental
osteomyelitis reproducibly without the use of a sclerosing agent or
trauma have been unsuccessful [28,31]. In preliminary experi-
ments we inoculated rabbits with 4610
6 CFU of the LAC strain,
either alone or concomitantly with ThrombovarH, and found that
the bone was sterile on D7 in respectively 3/5 and 0/6 animals.
The inoculum required to provoke osteomyelitis in humans is
not known, and could depend on both bacterial and host factors.
As in most experimental infections, the inoculum necessary to
induce osteomyelitis in rabbits may be higher than in humans.
Our use of two different inocula (low and high) and two time
points (D7 and D28) contributed to unmasking the role of PVL.
Osteomyelitis induced by the high inoculum closely mimicked
severe pediatric cases of PVL+ S. aureus infection described by
Figure 5. Anti-PVL antibody levels in sera of rabbits. Distribution
of anti-PVL antibody levels in 24 sera obtained before S. aureus
challenge (D0); 7 sera obtained 28 days after challenge with LACDpvl,9
sera obtained 28 days after challenge with a high inoculum of LAC, and
8 sera obtained 28 days after challenge with a low inoculum of LAC.
Bars show the median values. The median anti-PVL titer increased 31-
fold on D28 versus D0 after challenge with a high inoculum of LAC
(p,0.001). No significant change was detected at D28 versus D0 in
animals challenged with LACDpvl or with the low inoculum of LAC.
doi:10.1371/journal.pone.0007204.g005
Figure 6. C-reactive protein (CRP) values in rabbits. Distribution
of C-reactive protein (CRP) values in 36 rabbits (9 samples obtained on
D7 from rabbits infected with LAC, 9 samples obtained on D28 from
rabbits infected with LACDpvl, 9 samples obtained on D28 from rabbits
infected with LAC, and 9 samples obtained on D28 from rabbits
infected with LACDpvl (all animals challenged with the high inoculum).
Bars show the median values. The fall in the median CRP values from D7
to D28 was statistically significant for LACDpvl infection (p=002), but
not for LAC infection (p=.085).
doi:10.1371/journal.pone.0007204.g006
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Dohin et al [5] (early cortical bone deformation).
In addition, the choice of adequate experimental readouts is
critical. In our study, bacterial counts in bone – the classical
parameter used in therapeutic studies but one that is never
determined in human infections – were similar with the two
strains. In contrast, macroscopic findings, which are also used to
evaluate the severity of human osteomyelitis, were strain-
dependent and correlated closely with radiological and histopath-
ological findings.
In conclusion, our findings, obtained in a rabbit model of
osteomyelitis due to a PVL-expressing strain of S. aureus and its
isogenic PVL-negative derivative, supports the role of PVL as a
virulence factor that enhances bacterial persistence and local
spread. This is consistent with clinical reports of severe ostemyelitis
due to PVL-producing S. aureus strains in children. In addition to
clarifying the pathophysiologic role of PVL in osteomyelitis, our
experimental model should be suitable for assessing new treatments.
The erosion of the antibiotic armamentarium has prompted a
search for other ways to prevent and treat serious staphylococcal
infections. Our results call for the evaluation of new therapies to
combat PVL such as anti-PVL intravenous immunoglobulin.
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